[Arterial infusion chemotherapy for patients with advanced and moderately advanced cancer of urinary bladder].
OBJECTIVE
To study the effect of arterial infusion chemotherapy in patients with carcinoma of urinary bladder.


METHODS
Eleven patients with advanced or moderately advanced cancer of the urinary bladder (10 transitional cell carcinoma, 1 squamous-cell carcinoma) who were for various reasons not suitable for surgical treatment were treated by arterial infusion chemotherapy according to Seldinger's percutaneous approach.


RESULTS
The treatment results were satisfactory with an overall response rate of 90.9% (CR = 2, PR = 8). The average survival time of the 11 patients was 26.2 +/- 13.1 months. The 1-year survival rate was 81.8%. Side effects were mild.


CONCLUSIONS
Arterial infusion chemotherapy is of use in patients with advanced or moderately advanced bladder cancer.
Li
Q
Q
Department of Urology, Anzhen Hospital, Beijing.
Xu
X
X
Liu
J
J
D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000473:pathology; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000473:pathology; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007261:Infusions, Intra-Arterial; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage; D009367:Neoplasm Staging; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014750:Vincristine / Q000008:administration & dosage
D016685:Mitomycin; D014750:Vincristine; D002945:Cisplatin